These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36764415)

  • 21. Gemcitabine hydrochloride-loaded liposomes and nanoparticles: comparison of encapsulation efficiency, drug release, particle size, and cytotoxicity.
    Yalcin TE; Ilbasmis-Tamer S; Ibisoglu B; Özdemir A; Ark M; Takka S
    Pharm Dev Technol; 2018 Jan; 23(1):76-86. PubMed ID: 28724327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron complexation to histone deacetylase inhibitors SAHA and LAQ824 in PEGylated liposomes can considerably improve pharmacokinetics in rats.
    Wang Y; Tu S; Steffen D; Xiong M
    J Pharm Pharm Sci; 2014; 17(4):583-602. PubMed ID: 25579435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization and efficacy study of synergistic vincristine coloaded liposomal doxorubicin against breast and lung cancer.
    Ghosh S; Lalani R; Maiti K; Banerjee S; Patel V; Bhowmick S; Misra A
    Nanomedicine (Lond); 2020 Nov; 15(26):2585-2607. PubMed ID: 33090073
    [No Abstract]   [Full Text] [Related]  

  • 24. Synergy of the combination of nedaplatin with etoposide in murine and human lung carcinoma.
    Uchida N; Kasai H; Takeda Y; Maekawa R; Sugita K; Yoshioka T
    Anticancer Res; 1998; 18(1A):247-52. PubMed ID: 9568085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of PEGylated liposomes to prolong the circulation lifetime of salvianolic acid B.
    Zhang L; Han L; Sun X; Gao D; Qin J; Wang J
    Fitoterapia; 2012 Jun; 83(4):678-89. PubMed ID: 22391022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation, optimization, and characterization of topotecan loaded PEGylated liposomes using factorial design.
    Vali AM; Toliyat T; Shafaghi B; Dadashzadeh S
    Drug Dev Ind Pharm; 2008 Jan; 34(1):10-23. PubMed ID: 18214751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a controlled-release drug delivery system made of oleanolic acid formulated into multivesicular liposomes on hepatocellular carcinoma in vitro and in vivo.
    Luo Y; Liu Z; Zhang X; Huang J; Yu X; Li J; Xiong D; Sun X; Zhong Z
    Int J Nanomedicine; 2016; 11():3111-29. PubMed ID: 27471381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
    Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
    J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo.
    Cai L; Wang X; Wang W; Qiu N; Wen J; Duan X; Li X; Chen X; Yang L; Qian Z; Wei Y; Chen L
    Int J Nanomedicine; 2012; 7():4499-510. PubMed ID: 22923988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Docetaxel in combination with metformin enhances antitumour efficacy in metastatic breast carcinoma models: a promising cancer targeting based on PEGylated liposomes.
    Vakili-Ghartavol R; Mehrabian A; Mirzavi F; Rezayat SM; Mashreghi M; Farhoudi L; Kharrazi S; Sadri K; Jaafari MR
    J Pharm Pharmacol; 2022 Sep; 74(9):1307-1319. PubMed ID: 35833585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preparation and pharmaceutical characterization of Marine-SSL].
    Zhang DQ; Cheng Y; Bai CL; Wu Q; Pang GH
    Zhong Yao Cai; 2011 May; 34(5):786-9. PubMed ID: 21954568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation.
    Yang T; Cui FD; Choi MK; Cho JW; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2007 Jun; 338(1-2):317-26. PubMed ID: 17368984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PEGylated liposomes as delivery systems for Gambogenic acid: Characterization and in vitro/in vivo evaluation.
    Tang X; Sun J; Ge T; Zhang K; Gui Q; Zhang S; Chen W
    Colloids Surf B Biointerfaces; 2018 Dec; 172():26-36. PubMed ID: 30125771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery.
    Gao D; Tang S; Tong Q
    Int J Nanomedicine; 2012; 7():3517-26. PubMed ID: 22848175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluation.
    Cheng L; Huang FZ; Cheng LF; Zhu YQ; Hu Q; Li L; Wei L; Chen DW
    Int J Nanomedicine; 2014; 9():921-35. PubMed ID: 24611009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.
    Xie Q; Deng W; Yuan X; Wang H; Ma Z; Wu B; Zhang X
    Eur J Pharm Biopharm; 2018 Jan; 122():87-95. PubMed ID: 29032193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation, antileukemia mechanism, pharmacokinetics, and biodistribution of a novel liposomal emodin.
    Wang T; Yin X; Lu Y; Shan W; Xiong S
    Int J Nanomedicine; 2012; 7():2325-37. PubMed ID: 22661889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation the Anti-Cancer Effect of PEGylated Nano-Niosomal Gingerol, on Breast Cancer Cell lines (T47D), In-Vitro.
    Behroozeh A; Mazloumi Tabrizi M; Kazemi SM; Choupani E; Kabiri N; Ilbeigi D; Heidari Nasab A; Akbarzadeh Khiyavi A; Seif Kurdi A
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):645-648. PubMed ID: 29580033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of an in vitro drug release assay of PEGylated liposome using bovine serum albumin and high temperature.
    Hioki A; Wakasugi A; Kawano K; Hattori Y; Maitani Y
    Biol Pharm Bull; 2010; 33(9):1466-70. PubMed ID: 20823558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Encapsulation of Nedaplatin in Novel PEGylated Liposomes Increases Its Cytotoxicity and Genotoxicity against A549 and U2OS Human Cancer Cells.
    El-Shafie S; Fahmy SA; Ziko L; Elzahed N; Shoeib T; Kakarougkas A
    Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32927897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.